I didn't think the article was so scathing. It was very inside baseball from my software engineer basis, hard to understand what he was getting at. On the other hand, the article about axovant (the $5mil cast off drug they spun into a 1.x billion dollar company and it apparently doesn't work), that article was persuasive that I should short this. How come the axovant stock hasn't collapsed.
No comments yet.